---
layout: default
title: Acetaldehyde Acetic Acid Alpine Strawberry Anhydro
parent: 僅模型預測 (L5)
nav_order: 83
evidence_level: L5
indication_count: 0
---

# Acetaldehyde Acetic Acid Alpine Strawberry Anhydro
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Compound (30 Components): Insufficient Data for Drug Repurposing Evaluation

## One-Sentence Summary

This submission contains a 30-ingredient complex formulation — including botanical extracts (Echinacea purpurea, Nux vomica seed, Lycopodium clavatum), animal-derived materials (cow milk, pork liver, adrenal gland, horseshoe crab), conventional pharmaceuticals (cortisone acetate, estrone, caffeine), and various excipients — that cannot be resolved to a single drug entity in any regulatory database.
The TxGNN model returned **no predicted indications** for this compound, and the formulation currently holds **no market authorization** in Taiwan.
Without a recognizable drug identity, DrugBank mapping, or approved indication, this candidate cannot proceed through standard repurposing evaluation at this time.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None identified — no regulatory approval record found |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | Below L5 (no predictions generated; model could not process multi-ingredient compound as a single entity) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

The TxGNN knowledge graph model is designed to operate on **single drug entities** mapped via DrugBank ID. This submission presents 30 distinct chemical and biological ingredients simultaneously as a single query string. Several structural issues prevent evaluation:

1. **No DrugBank ID was resolved.** TxGNN requires a valid DrugBank node as the starting point for graph traversal. Without this anchor, the model cannot compute disease proximity scores.

2. **Heterogeneous ingredient classes.** The formulation mixes conventional pharmaceuticals (cortisone acetate, estrone), herbal extracts (Echinacea purpurea, Strychnos nux-vomica seed), animal tissues (pork liver, Sus scrofa adrenal gland, Limulus polyphemus), and industrial excipients (paraffin, silicon dioxide, sodium bicarbonate). This composition pattern is characteristic of **isopathic or homeopathic compound preparations**, which lie outside the TxGNN training corpus.

3. **No mechanism of action data is available.** Without MOA information, the mechanistic rationale section cannot be completed.

---

## Safety Considerations

Please refer to the package insert for safety information.

> Note: Cortisone acetate and estrone are pharmacologically active ingredients present in this formulation. If this preparation is intended for clinical or investigational use, steroid-related and estrogen-related contraindications and drug interactions should be evaluated against current prescribing references prior to any human exposure.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
This compound cannot be evaluated under the current TxGNN drug repurposing framework because it does not resolve to a single identifiable drug entity with a DrugBank node, has no approved indication, and has no predicted disease associations. The presence of pharmacologically active steroids (cortisone acetate, estrone) in an otherwise homeopathic-style formulation also raises safety characterisation questions that must be resolved before any repurposing signal can be interpreted.

**To proceed, the following is needed:**

- **Drug identity clarification**: Determine whether this is a registered homeopathic/isopathic product; if so, identify the product name, manufacturer, and any existing regulatory dossier
- **Individual component analysis**: If repurposing evaluation is desired, consider submitting each pharmacologically active ingredient (cortisone acetate, estrone, caffeine) separately as individual TxGNN queries
- **DrugBank mapping**: Resolve at least the conventional pharmaceutical components to DrugBank IDs to enable graph-based prediction
- **TFDA package insert retrieval** (Data Gap DG001): Download and parse the prescribing information PDF to obtain approved warnings and contraindications
- **MOA documentation** (Data Gap DG002): Query DrugBank API for mechanism of action for each active component
- **Regulatory status clarification**: Confirm whether this product is marketed under any national pharmacopoeia, homeopathic registry, or special licence in any jurisdiction
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

